KAT III is an abbreviated term for a member of the lysine acetyltransferase family, a group of enzymes that play a crucial role in acetylation, a form of post-translational modification. This process is essential for regulating the function of various proteins and is involved in numerous cellular processes including gene expression, protein stability, and signal transduction. While specific details on KAT III are not widely documented, understanding the general mechanisms of how lysine acetyltransferases are regulated can provide insights into the potential induction of KAT III expression. Such enzymes are often regulated at the transcriptional level by changes in cellular environment and by interplay with other proteins and signaling pathways. As such, the expression of KAT III may be similarly controlled by intricate cellular mechanisms that respond to various molecular cues.
Several chemical compounds have been identified that can potentially act as activators to induce the expression of lysine acetyltransferases, and by extension, could be presumed to have a similar influence on KAT III. Resveratrol, for instance, is a polyphenolic compound found in grapes and berries that might increase the expression of KAT III through its interaction with sirtuin proteins, which are known to be involved in the regulation of acetyltransferases. Similarly, compounds such as sodium butyrate, a short-chain fatty acid found in dietary fibers, could elevate KAT III expression due to its role as a histone deacetylase inhibitor, thereby influencing the acetylation landscape within cells. Other molecules like curcumin, found in the spice turmeric, might also induce KAT III expression given its broad influence on cell signaling and gene regulation. It is a collection of such diverse compounds, each with unique molecular characteristics, that could potentially serve as activators of KAT III, shaping the acetylation patterns and contributing to the dynamic regulation of cellular functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol may stimulate KAT III expression by activating sirtuin pathways, which could increase the demand for acetyltransferase activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
By inhibiting histone deacetylases, sodium butyrate might create an environment that requires the upregulation of KAT III to restore acetylation balance. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid, another HDAC inhibitor, could potentially lead to an upsurge in KAT III expression to counter the increased histone acetylation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin could stimulate the transcription of KAT III due to its role in controlling inflammatory response pathways that intersect with gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may induce KAT III expression as a compensatory response to the increased acetylation levels resulting from HDAC inhibition. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid may increase KAT III expression by altering the epigenetic landscape, thereby necessitating a rebalance of acetylation through KAT III activity. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $136.00 $492.00 | 13 | |
As a histone acetyltransferase inhibitor, garcinol might induce the expression of KAT III to compensate for the inhibition of acetylation. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
This compound may upregulate KAT III expression by inhibiting other acetyltransferases, thus requiring a compensatory response from KAT III. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Nicotinamide might stimulate KAT III expression as it inhibits sirtuin deacetylases, potentially creating a need for increased acetyltransferase activity. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
DL-Sulforaphane may induce KAT III expression through its role in antioxidant response pathways, which may intersect with histone acetylation processes. | ||||||